Bridging the Coverage Gap

The FDA approves breakthroughs; RegenMed ensures they get paid for. We provide the decentralized infrastructure to capture Deterministic Evidence post-launch — transforming clinical mastery into the longitudinal proof required to override payer denials and secure market scale.
Go Deeper

The "Twin Sins" of Market Access

The Problem: Carriers often rely on "Data Exhaust"— messy billing codes and secondary claims data — to evaluate new therapies.  Because this data lacks clinical depth, payers are forced to infer value, leading to structural friction.
The Commercial Bottlenecks:
The Sin of Omission
High-value, FDA-approved devices are denied via prior authorization because the "exhaust" doesn't show the nuanced, real-world success of the procedure.
The Static Rulebook
Payers default to the cheapest traditional options because they are "pre-negotiated" and cannot be easily refuted by current, messy data sets.
Revenue Cycle Erosion
Innovative practices face a "sustainability test" where the administrative burden of proving value to insurers outweighs the clinical benefit.

Fee-for-Veracity: Moving Beyond the Guess

The Solution:  RegenMed replaces "guesses" with Ground Truth by defining the clinical evidence structure before the treatment occurs.
The Veracity Advantage:
Deterministic Proof
Provide carriers with high-fidelity, longitudinal datasets that prove effectiveness in a format their "static rulebooks" cannot ignore.
Outcome Adjudication
Enable real-time verification of clinical results, moving the conversation from "trusting doctors" to "engineering truth".
Structured Note Defense
Capture regulatory-grade evidence as a byproduct of the physician's existing workflow, eliminating the administrative "hoops" that delay care.

The Clinical Legacy

Treating the Patient, Not the X-Ray

Ensure individualized, context-driven care is reimbursed by providing the data that validates customized patient pathways.

Sustainability for Independent Practices

Protect practice revenue from "quiet" RVU cuts by proving the specific value of innovative interventions.

Scientific Sovereignty

Empower clinicians to define the standards of their specialty through verifiable evidence, not administrative mandates.

The Infrastructure for Market Access

1.4m+
Structured Datapoints
75+
Active Specialty Protocols
3X
YoY Network Growth
The Evidence Vault
Access our "Case Study on Coverage Gap Elimination" and the "White Paper on Regulatory-Grade Post-Market Surveillance".
Visit The Vault

Not finding the info you need?

EMAIL US

Have a specific question? Write to us at circles@rgnmed.com and we'll respond promptly with the details you need.
Email us

BOOK A MEETING

Prefer a personal chat? Schedule a quick call with our team to get tailored advice and answers in real time.
Book a meeting
Scroll Up Arrow